by The demineralized bone matrix (DBM) market involves the manufacturing and processing of bone tissues and allografts. DBM is derived from human bones and comprises collagen, non- collagenous proteins, and bone morphogenic proteins. It acts as an osteoinductive bone graft material and facilitates new bone formation. DBM is extensively used in orthopedic surgeries such as spinal fusion, bone fracture treatments, and reconstructive procedures. The global demand for DBM has grown significantly due to its properties of osteoconduction and osteoinduction.
The Global Demineralized Bone Matrix Market is estimated to be valued at US$ 733.13 Mn in 2024 and is expected to exhibit a CAGR of 4.3% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the demineralized bone matrix market are Medtronic Plc, Johnson Johnson (DePuy Synthes), Exactech, Inc., HansBioMed, Xtant Medical, Stryker, Arthrex GmbH, RTI Surgical, Zimmer Biomet., and Straumann. Key players are focusing on new product launches, strategic partnerships, and increasing their regional presence to capitalize on growth opportunities.
Demineralized Bone Matrix Market demand include addressing the increasing for bone grafts driven by rising sports and road injuries and a higher number of dental restoration procedures due to increased expenditure on dental care. Geographic expansion into emerging nations and improving access to advanced medical technologies are also key factors propelling market growth. Major market players are focusing on geographical expansions to enhance product availability and uptake in high-growth markets.
Global expansion of key players through collaborations and acquisitions will help strengthen their geographic presence. Rising medical tourism in developing nations will further aid the global expansion of the DBM market over the forecast period.
Market drivers
Rising number of orthopedic and spinal surgeries is a key driver propelling growth of the demineralized bone matrix market. According to the United Nations Population Fund (UNFPA), the number of hip and knee replacements is projected to rise by 673% in
developing nations between 2010 and 2030. DBM facilitates bone fusion and healing, thus, finding widespread adoption in orthopedic repair and reconstruction procedures.
Additionally, growing geriatric population globally that is more prone to orthopedic diseases will further augment demand.
PEST Analysis
Political: Demineralized Bone Matrix (DBM) products are regulated as medical devices by the US Food and Drug Administration (FDA). Any changes in the regulatory structure surrounding medical devices sales could impact the market.
Economic: The overall growth of the economy and disposable income levels will impact spending on elective medical procedures that utilize DBM products. The demineralized bone matrix market is also influenced by reimbursement policies related to orthopedic procedures. Social: An aging population prone to orthopedic conditions and trauma cases drives demand for orthopedic procedures and grafting/healing products like DBM. Growing public awareness about grafting techniques could influence market trends.
Technological: Continuous research is being conducted to develop advanced formulations of DBM products with improved handling properties and osteoinductive capability. 3D printing and tissue engineering applications also offer new potential uses for DBM.
The strong presence of leading global manufacturers also positions the US market favorably. This highlights key insights in the Demineralized Bone Matrix Market Regions Analysis Rising volume of orthopedic and spinal surgeries worldwide presents significant opportunities for players in the DBM market. Furthermore, sports injuries, trauma injuries, and age-related orthopedic diseases are on the rise, thereby propelling demand for bone grafting procedures that use DBM
The Asia Pacific region has emerged as the fastest growing regional market for demineralized bone matrix over the past few years. Increasing disposable incomes, growth of medical tourism, rising prevalence of orthopedic conditions among the large population base are some key factors supporting market gains in the Asia Pacific region. Wide acceptance of tissue grafting techniques in countries like India, Japan and China has further expanded the potential consumer pool in the region.
*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it
About Author - Ravina Pandya
Ravina Pandya,a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals. LinkedIn Profile
